Health Detectors is a 5-day evidence-based executive health program in Munich. 25+ biomarkers, specialist diagnostics, and a personalized risk report — all grounded in the latest medical evidence.
Standard health checks don't reduce mortality — the Cochrane Review of 251,891 patients proved it. Untargeted screening leads to overdiagnosis, not better health.
Health Detectors is different. We use risk-stratified, evidence-based protocols that focus resources where they can actually change outcomes.
Limited time for comprehensive risk assessment. Important conditions go undetected.
Lack scientific rigor. Tests without evidence. No structured follow-up.
Often skip evidence discipline entirely. Supplements over science.
Evidence-based. Risk-stratified. Every finding comes with a plan.
From digital intake to your personalized risk report, every step is designed to give you actionable answers.
Complete your medical history, family history, lifestyle, and prior records from home — securely online.
Fasting blood draw (25+ analytes), physician consultation, fitness assessment (VO₂max, grip strength, body composition).
Enjoy Munich while your lab results are processed. Explore the city, relax, take a day trip.
Risk-stratified specialist modules: cardiology, metabolic, oncology, dermatology, imaging — tailored to your results.
60-minute closing session. Evidence-graded risk report + action plan. Includes 6-week telemedicine follow-up.
Every patient completes DETECT — a comprehensive laboratory panel and fitness assessment that forms the foundation for your personalized plan.
ApoB, Lipoprotein(a), Triglycerides, HDL-C — atherogenic particle count and risk markers
4 biomarkersFasting Glucose, HbA1c, Insulin/HOMA-IR, Uric Acid — catch insulin resistance years before diabetes
4 biomarkersTSH as first-line screen — with reflex fT3/fT4 if abnormal. Subclinical dysfunction affects 5–10% of adults.
1 biomarker + reflexhs-CRP for systemic inflammation, Complete Blood Count with differential — anemia, infection, and more
2 panelsLiver (ALT/AST/GGT, ALP, LDH), Pancreas (Lipase), Kidney (Creatinine/eGFR), Total Protein/Albumin
6 biomarkersSodium, Potassium, Calcium, Magnesium, Phosphate — essential baselines and medication safety
5 biomarkersVitamin D, Ferritin, Vitamin B12 — deficiency prevalence is 20–40% in the general population
3 biomarkersBased on DETECT findings, your physician recommends specialist modules. You decide which to pursue. Every module is evidence-graded.
Cardiologist consult, ECG, echocardiography, carotid duplex, exercise testing, coronary calcium scoring
★★★ High EvidenceAbdominal ultrasound, DEXA body composition & bone density, extended lipid panel
★★★ High EvidenceGI specialist consult, colonoscopy with sedation, pathology — colorectal cancer screening & prevention
★★★ High EvidenceGynecology consult, Pap smear, transvaginal US, breast ultrasound, 3D mammography
★★★ High EvidenceUrology consult, PSA with shared decision-making, prostate US, mpMRI if indicated
★★★ High EvidenceMale or female hormone panel — for symptoms like fatigue, libido changes, perimenopause
★★ Moderate EvidenceFull-body dermatoscopy, digital documentation, excision & histopathology if indicated
★★★ High EvidenceWhole-body MRI, brain MRA, low-dose chest CT — for high-risk profiles only, with informed consent
★★–★★★ SelectiveThese tests represent the frontier of preventive medicine. Each is labeled with its evidence level and limitations. Never necessary — always transparent.
DNA methylation analysis measuring your rate of aging. Validated in the CALERIE randomized trial. Repeatable, actionable through lifestyle changes.
★ Emerging · Validated in RCTCell-free DNA blood test detecting signals from 50+ cancer types. 99.5% specificity. Currently in NHS trial with 140,000 participants.
★ Emerging · FDA BreakthroughEPA+DHA percentage in red blood cells. Levels ≥8% are associated with significantly lower risk of sudden cardiac death. Actionable through diet and supplementation.
★ Emerging · ActionableIGF-1 (somatotropic axis), Cystatin C (precise kidney function), Fibrinogen (clotting/inflammation) — selected based on your clinical profile.
★ Emerging · Profile-DependentIf there's no evidence a test improves outcomes, or if harm outweighs benefit, we don't offer it — no matter how popular it may be.
Munich combines Europe's finest medical infrastructure with a city that makes your visit a pleasure — not a chore. Spend Day 2 exploring while your labs process.
Our clinical network consists of outstanding board-certified specialists in private practice and radiology centers with high-end equipment in and around Munich.
Health Detectors is led by a medical-scientific advisory board with deep roots in academic medicine and clinical practice.
We use a transparent classification system so you always know how strong the evidence is behind each test and recommendation.
Multiple randomized trials, large cohorts, or Level-I guidelines. Recommended to every eligible patient.
Good observational data, individual trials. Offered with shared decision-making.
Plausible, active research, no mortality data yet. LONGEVITY module only. Clearly labeled.
Insufficient evidence or harm exceeds benefit. Excluded with reasoning.
After years navigating the US healthcare system as patients, Vernon and Cathy Suzuki built the program they couldn't find.
251,891 patients. 17 trials. Zero mortality benefit. What the largest health-screening review ever conducted actually found.
Traditional LDL-C is an estimate. ApoB counts every atherogenic particle, and Lipoprotein(a) reveals a genetic risk affecting 1 in 5 people.
Begin with a confidential conversation. We'll answer your questions and help you decide if Health Detectors is right for you.
Start Your Conversation →